CRNX Competitors & Alternatives
Compare Crinetics Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
CRNX
Main Stock$36.18
Tradestie Score
60
Market Cap
$3.92B
Revenue Growth
28.7%
Analyst Upside
+129.8%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PTGX
Protagonist Therapeutics, Inc
|
$122.15
|
$3.98B | - | 67 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$99.87
|
$3.91B | - | 53 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$18.37
|
$3.83B | - | 57 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$17.08
|
$3.68B | - | 58 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$114.97
|
$3.67B | - | 57 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$8.70
|
$3.59B | 12.8 | 61 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$23.36
|
$3.58B | 10.2 | 67 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$284.91
|
$3.49B | 36.4 | 65 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$10.90
|
$3.40B | - | 58 | Compare |
|
QURE
uniQure N.V.
|
$48.85
|
$3.39B | - | 63 | Compare |
More CRNX Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2834)
225 stocks in this industry